Christine Willinger — University of California System

Area of research

Molecular Biology · Endocrinology, Diabetes and Metabolism

Research interest

Research focused on Dyslipidemia and Mendelian randomization, with related work in Lipidome, DNA methylation, Psoriatic arthritis. Notable publications include 'Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach', 'Lipidomic profiling identifies signatures of metabolic risk', and 'Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease'.

Recent publications

Lipidomic profiling identifies signatures of metabolic risk

EBioMedicine 2019cited by 87position: middledoi

Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease

The Journal of Rheumatology 2019cited by 25position: middledoi

Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach

PLoS Medicine 2017cited by 390position: middledoi

Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes

The Journal of Clinical Endocrinology & Metabolism 2016cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Molecular Biology · Endocrinology, Diabetes and Metabolism →